Skip to main contentSkip to navigation
Sirius Investors
Merrimack Pharmaceuticals, Inc.

Merrimack Pharmaceuticals, Inc.

MACK
NASDAQHealthcare

MACK Financial Statements & Analysis

Complete financial statements for MACK including income statement, balance sheet, and cash flow statement. Analyze MACK's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.

TTM figures are calculated by rolling up the last four quarterly filings (income and cash flow summed; balance sheet at period end).

Financial Health Score

Financial Health Score

/100
Unlock score for free

Already registered? Sign in

Income Statement

Revenue
0.0%
Net Income
-2341.8%
Gross Margin
0.0%
Operating Margin
0.0%

Balance Sheet

Current Ratio
-75.2%
Debt to Equity
0.0%
Asset Turnover
0.0%

Cash Flow

Operating Cash Flow
-62.9%
Net Cash Flow
1696.7%
Free Cash Flow
-62.9%
Cash Flow to Debt
-62.9%

Income Statement Comparison

Revenue & Net Income

Period Comparison

MetricTTM Q4 '23TTM Q1 '24ChangeImpact
Revenue000.0%
Gross Profit000.0%
Operating Income-2.04M-2.26M10.9%
Net Income-1.00M-24.54M2341.8%
EPS-0.02-0.432333.3%
EBITDA-754.00K-976.00K29.4%
Gross Margin0.00%0.00%0.0%
Operating Margin0.00%0.00%0.0%
Net Income Margin0.00%0.00%0.0%
R&D Expenses278.00K139.00K50.0%

Income Statement Full Table

Free users can view the last 3 periods. Upgrade to see the full history.

Upgrade
MetricTTM Q1 '24TTM Q4 '23TTM Q3 '23TTM Q2 '23TTM Q1 '23
Revenue00-445.00K
Gross Profit00-890.00K
Operating Income-2.26M-2.04M-2.15M
Net Income-24.54M-1.00M-1.26M
EPS-0.43-0.02-0.02
EBITDA-976.00K-754.00K-1.02M
Gross Margin0.00%0.00%200.00%
Operating Margin0.00%0.00%484.04%
Net Income Margin0.00%0.00%282.47%
R&D Expenses139.00K278.00K139.00K

Our detailed financial analysis helps investors understand MACK's business performance, operational efficiency, and financial health through comprehensive financial statement data presented in both quarterly and annual formats.

Track MACK's financial performance metrics including revenue, gross profit, operating income, net income, total assets, liabilities, shareholders' equity, operating cash flow, and free cash flow with historical comparison and trend analysis.

Financial Metrics

Want to dive deeper into MACK's financial health? Explore key financial metrics and ratios including profitability, liquidity, efficiency, and valuation metrics.

View Financial Metrics
Merrimack Pharmaceuticals, Inc. (MACK) Financial Statements (2026): Income, Balance Sheet & Cash Flow | Sirius Investors